- 期刊
Successful Discontinuation of Secondary Prophylaxis for Histoplasmosis after Highly Active Antiretroviral Therapy
對於愛滋病患的組織徽菌感染在使用高效能抗愛滋病毒藥物後停用次級抗徽菌預防用藥的病例報告
並列摘要
Whether maintenance antifungal prophylaxis against histoplasmosis should be continued life-long in patients with immune restoration after highly active antiretroviral therapy (HAART) remains unclear. We report a case of disseminated histoplasmosis involving the skin, lung, gastrointestinal tract, mesentery, and retroperitoneum in a 33-year-old man with acquired immunodeficiency syndrome. His symptoms improved after use of amphotericin B and itraconazole in addition to ileostomy to relieve the intestinal obstruction. After the start of HAART, he was able to discontinue itraconazole as maintenance therapy without relapse for 24 months.
延伸閱讀
- 鄭威、張珮文（2018）。他山之石可以攻錯：PrEP暴露愛滋病毒前預防性投藥－美國使用現況。臺灣醫界，61(7)，24-25。https://www.airitilibrary.com/Article/Detail?DocID=17263603-201807-201807180013-201807180013-24-25
- Chang, L. R., Pan, S. C., Lee, J. W., & Chiu, H. Y. (2007). 依照病患免疫狀態合物併使用外科及抗黴菌藥物成功地治療廣泛性原發性球菌感染－兩病例報告. 中華民國整形外科醫學會雜誌, 16(2), 145-153. https://doi.org/10.7096/JPSA.200706.0145
- 林佳諄（2019）。愛滋感染者在高效能抗反轉錄病毒治療後病毒抑制失敗之相關因素〔博士論文，中山醫學大學〕。華藝線上圖書館。https://doi.org/10.6834/CSMU201900061
- Yeh, M. L. (2019). 慢性B型與C型肝炎合併感染應用長效干擾素合併雷巴威林或全口服直接作用抗病毒藥物治療之世代性研究 [doctoral dissertation, Kaohsiung Medical University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0011-0507201914532600
- Chen, S. Y. (2017). 發展急診病人抗藥性金黃色葡萄球菌與多重抗藥性格蘭氏陰性菌預測模式以預防抗藥性細菌於醫院內傳播 [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU201704129